Joseph P. Lyssikatos - CHIEF SCIENTIFIC OFFICER at Enliven Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Scientific Officer
Issuer Symbol
ELVN on Nasdaq
All Insider Reports
All Insider Reports

Joseph P. Lyssikatos - trading volume in the past year for Enliven Therapeutics, Inc.

Holdings reported by Joseph P. Lyssikatos for Enliven Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 740,188 $18,785,971 $25.38 12 Feb 2026 Indirect
Common Stock 18,750 $475,875 $25.38 12 Feb 2026 Direct
Stock Option (right to buy) 112,500 12 Feb 2026 Direct Common Stock

Transactions reported by Joseph P. Lyssikatos for Enliven Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.